Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient

NCT07198217 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Tislelizumab
Chemotherapy
Hypofractionated Radiotherapy

Interventions

DRUG: SBRT combined with Tislelizumab followed by Tislelizumab

Sponsor

Zibo Municipal Hospital